Application | Comment | Organism |
---|---|---|
additional information | knowledge of the GSTz1/MAAI haplotype can be used prospectively to identify individuals at potential risk of dichloroacetates adverse side effects from environmental or clinical exposure or who may exhibit aberrant amino acid metabolism in response to dietary protein | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
gene GSTz1/MAAI is located on chromosome 14q24.3, genotyping, overview | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Dichloroacetate | the sensitivity to the inhibitor varies between enzyme haplotypes. Three nonsynonymous single-nucleotide polymorphisms of GSTz1/MAAI show different activity toward dichloroacetate and certain other xenobiotic haloacids | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | the bifunctional enzyme dehalogenates dichloroacetate to glyoxalate via its zeta-1 family glutathione transferase activity. Dichloroacetate is relevant to environmental science and allopathic medicine. The sensitivity to the inhibitor varies between enzyme haplotypes. Three nonsynonymous single-nucleotide polymorphisms of GSTz1/MAAI show different activity toward dichloroacetate and certain other xenobiotic haloacids | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
glutathione transferase zeta 1/maleylacetoacetate isomerase | - |
Homo sapiens |
GSTz1/MAAI | - |
Homo sapiens |
MAAI | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | human polymorphisms in the glutathione transferase zeta 1/maleylacetoacetate isomerase gene influence the toxicokinetics of dichloroacetate, GSTz1/MAAI haplotype significantly affects the kinetics and biotransformation of dichloroacetate. GSTz1/MAAI variants associated with the slowest rates of dichlorocacetate metabolism induce structural changes in the enzyme homodimer, predicting protein instability or abnormal protein-protein interactions. Enzyme inhibition also results in the accumulation of the potentially hepatotoxic tyrosine intermediates maleylacetoacetate and maleylacetone and of delta-aminolevulinate | Homo sapiens |
metabolism | the bifunctional enzyme glutathione transferase zeta/maleylacetoacetate isomerase is the penultimate enzyme in the phenylalanine/tyrosine catabolic pathway | Homo sapiens |